Business in 9M/2018 was 1,106.80 million Baht, decreased by 66.57 million Baht or 5.67% as compared to same period of 2 017 due to the decreasing of household customers and the higher cost from purchasing
previous year. This came from decreasing in services revenue whereas sales revenues from medical devices still increased. Revenues from sales and services of EFORL and its subsidiaries in Q3/2018 increased
Unit: THB mm average cost of fund of the Company in 2019 decreased by 0.47% (decreasing from 3.88% in 2018 to 3.41% in 2019). During 2019, the Company had utilized additional short-term and long-term
do not exceed 1:1 and are in compliance with the 4 policy of the Company. The cost management of the Company is very efficient. The interest cost is lower than 3%, decreasing from 4% as a result of the
-bearing debt to equity ratio of 2.41x, decreasing from 2.49x as of 31 December 2019. This was caused by decreased interest-bearing liabilities due to repayment of long- term loans and leasing loans as well
decreasing due to the impact of COVID-19 outbreak, such preventive measures of social distancing and curfew. It caused the Group had to improve budget costs control in some projects. Such as increased costs of
decreasing Baht 0.47 million or approx. 58.02% decrease. The approximate 30.52 % were gained from the interest receivable of bank deposit. Cost of Construction The company and subsidiaries’ cost of
million and loss on loan to subsidiary of Baht 350 million. The loss for the period of YE 2019 is Baht 358 million decreasing by 42% from last year (YE2018: 621 million). However the Company is in the
revenue of 3,648 million Baht, increased by 42% YoY and 101% QoQ, mainly due to revenue from the ESSE Asoke. Net profit of Q4’2018 was 305 million Baht, decreased by 53% YoY and 4% QoQ. Decreasing in net
borrowings, decreasing from 75% of fiscal year 2018. To manage risk that might occur from the fluctuation in currency and interest rate of long-term a debenture in foreign currencies, the Company has entered